scholarly journals Optimizing Outcomes Beyond Day +100: Process for Identifying and Managing High-Risk Allogeneic Transplant Recipients

2017 ◽  
Vol 23 (3) ◽  
pp. S451-S452
Author(s):  
Sheila Serafino ◽  
Navneet S. Majhail ◽  
Julie Curtis ◽  
Laura Bernhard ◽  
Sharon Caroniti ◽  
...  
2020 ◽  
Vol 22 (3) ◽  
Author(s):  
Hannah Imlay ◽  
Allison O. Dumitriu Carcoana ◽  
Cynthia E. Fisher ◽  
Beatrice Wong ◽  
Robert M. Rakita ◽  
...  

2000 ◽  
Vol 69 (Supplement) ◽  
pp. S114-S115
Author(s):  
Jeffrey S. Zaltzman ◽  
Vivian C. McAlister ◽  
David Russell ◽  
Phillip F. Halloran ◽  
David N. Landsberg ◽  
...  

2013 ◽  
Vol 13 (5) ◽  
pp. 622-628 ◽  
Author(s):  
Lynne Strasfeld ◽  
Luis Espinosa-Aguilar ◽  
James L. Gajewski ◽  
Peter Stenzel ◽  
Agustin Pimentel ◽  
...  

2007 ◽  
Vol 17 (3) ◽  
pp. 180-182 ◽  
Author(s):  
Jerome F. O'Hara ◽  
Katrina Bramstedt ◽  
Stewart Flechner ◽  
David Goldfarb

Evaulating patients for living kidney donor transplantation involving a recipient with significant medical issues can create an ethical debate about whether to proceed with surgery. Donors must be informed of the surgical risk to proceed with donating a kidney and their decision must be a voluntary one. A detailed informed consent should be obtained from high-risk living kidney donor transplant recipients as well as donors and family members after the high perioperative risk potential has been explained to them. In addition, family members need to be informed of and acknowledge that a living kidney donor transplant recipient with pretransplant extrarenal morbidity has a higher risk of a serious adverse outcome event such as graft failure or recipient death. We review 2 cases involving living kidney donor transplant recipients with significant comorbidity and discuss ethical considerations, donor risk, and the need for an extended informed consent.


Sign in / Sign up

Export Citation Format

Share Document